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Natural Product Hybrids
Karl Gademann*
Abstract: this review highlights several classes of natural product hybrids. First, structural hybrids emanating from 
different biosynthetic pathways exemplified by the polyketide peptide alkaloid anachelin are discussed. Another 
class is the so-called functional hybrids, where different functions of natural products are hybridized. the conju-
gate between nostocarboline and the well-known antibacterial agent ciprofloxacin displays a very broad spectrum 
of activity combining photosynthesis and gyrase-inhibiting activity. Last, higher order hybrids are discussed. We 
present the ternary hybrid of titanium dioxide, the anachelin chromophore and poly-ethyleneglycol (pEG). this 
chimera allows for the functionalization of tio2 surfaces to render those protein resistant. this article thus shows 
how natural products can be hybridized to generate compounds with unprecedented bioactivity thus enabling the 
development of novel drugs and advanced materials.
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thetic organic chemistry. The goal of this 
highlight article is to demonstrate that the 
biological functions of natural products 
can be expanded, combined and lever-
aged by so-called natural product hybrids 
(sometimes also referred to as chimeras or 
conjugates). This strategy is not limited to 
natural products themselves, as also syn-
thetic compounds, from small molecules 
to polymers, can be hybridized to generate 
compounds with unprecedented functions. 
This highlight article will focus on our own 
work, as excellent general reviews on this 
subject have been published [4].
Analysis of natural products reveals an 
interesting pattern as many of these com-
pounds are composed of substructures orig-
inating either from different biosynthetic 
pathways or containing several biological 
functions. These fragments are hybridized 
by nature to generate naturally occurring 
conjugates. Such hybrids include the well-
known glycosylated steroids, glycosylated 
or lipidated peptides, or polyketide alka-
loids. In lipidated peptides, the lipid part is 
responsible for anchoring these compounds 
in biomembranes and the peptide part can 
exert the main biological function [5].
In this highlight article, we will discuss 
three classes of natural product hybrids rel-
evant to our own work. The first example 
is a hybrid of different biosynthetic path-
ways (structural hybrid). The second part 
will demonstrate the hybridization of func-
tions thus broadening the biological activity 
(functional hybrid). The last example will 
show how this concept can be expanded to 
generate ternary conjugates (higher order 
hybrids).
2. Anachelin – A Structural Hybrid
Siderophores are small molecules se-
creted by microorganisms to bind and se-
quester iron [6]. Our initial interest in these 
compounds originated from the historical 
evolution of earth’s atmosphere. Initially, 
the earth was thought to contain a reduc-
tive atmosphere in which the early life 
forms flourished [7]. Their need for iron 
was supplemented by readily available and 
soluble Fe(ii) salts [7]. Among these an-
cient organisms were also cyanobacteria 
(blue-green algae), with fossils dating their 
initial presence 3.5 billions years ago [8]. 
These organisms probably also developed 
and introduced photosynthesis on this plan-
et and were thereby directly responsible for 
the release of oxygen [8]. Such a very suc-
cessful photoautotrophic strategy led how-
ever to a change in earth’s atmosphere as 
the reductive environment slowly changed 
into an oxidative one, as it is to this day. 
This change had dramatic consequences for 
many life forms present at that time as oxy-
gen is both a potent oxidant and cell poison. 
Life forms surviving this disaster were soon 
faced with another challenge: Oxidation of 
the soluble Fe(ii) salts to the correspond-
ing virtually insoluble Fe(iii), species of 
which the dominant iron oxide hydrates are 
in general not soluble (“the world rusted”) 
[7]. Iron acquisition thus became a chal-
lenge for every organism. Although cyano-
bacteria probably caused this atmospheric 
change a long time ago, there is little known 
so far how these organisms faced this chal-
lenge and in particular, about complex cya-
nobacterial siderophores [8–10].
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1. Introduction
Natural products, i.e. chemical entities pro-
duced by living organisms such as bacteria, 
fungi and plants, have historically provided 
important molecular solutions to medical 
problems [1]. While extracts of plants have 
been traditionally used, the improvement 
of analytical techniques has facilitated the 
isolation and characterization of the active 
principles, the so-called natural products. 
Improved understanding of the mode of ac-
tion of such compounds combined with the 
synthesis of derivatives enables the estab-
lishment of structure–activity relationships 
and thus the generation of more active, 
synthetic derivatives. This general strategy 
remains the most promising way to gener-
ate potent and selective biologically active 
compounds [2]. These statements are sup-
ported by analyses of new chemical enti-
ties introduced on the market in the period 
1981 to 2002 [3]. Among these compounds 
around 40% are of natural origin or syn-
thetic derivatives thereof. These numbers 
underline the tremendous importance of 
natural products in drug discovery.
The evolutionary wisdom enshrined in 
natural products can be unlocked by syn-
doi:10.2533/chimia.2006.841 
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In 2000, the first complex siderophore 
from the cyanobacterium Anabaena cy­
lindrica CCAP 1403-2a was isolated and 
named anachelin (1), as a mixture of two 
compounds [11] (Fig. 1). Later, additional 
isomers were reported [12]. The historical 
postulate outlined above that cyanobacteria 
were among the first organisms to encounter 
iron scarcity and met this challenge by use 
of small molecule siderophores stimulated 
us to initiate a research program aimed at 
these questions. In addition, the structure of 
anachelin (1) is appealing to the chemist. At 
least three different biosynthetic pathways 
are combined: The polyketide fragment, 
the peptide part featuring a non-standard 
d-amino acid, and the alkaloid fragment. In 
addition, the origin of the salicylate part is 
unknown and two biosynthetic pathways are 
likely for its generation. Therefore, anache-
lin (1) can be considered a structural natural 
product hybrid based on fragments of differ-
ent biogenetic origin. We have investigated 
the solution structure of anachelin [13], the 
possible biosynthesis [14] and the mode 
of action of 1 [15], and completed its total 
synthesis thereby establishing the configura-
tion [16][17]. This research enabled also the 
venture into surface functionalization using 
these compounds, as discussed below.
3. Functional Hybrids Based on 
Nostocarboline
Cyanobacteria (often referred to as blue-
green algae) are unicellular prokaryotic or-
ganisms. These photoautotrophs are among 
the oldest life-forms still present today on 
Earth and survived by populating almost 
every available ecological niche, from ice 
to rocks, from the open ocean to the fur of 
polar bears. In particular in warm and humid 
or aquatic habitats, intense competition for 
nutrients and light characterizes the evolu-
tionary pressure on the organisms. In addi-
tion and similar to plants, cyanobacteria can 
encounter pressure by grazing organisms. 
Therefore, it is not surprising that cyano-
bacteria developed sophisticated chemical 
defense strategies for survival. Many me-
tabolites are thought to be produced in or-
der to gain an evolutionary advantage over 
competing organisms [18]. One example, 
anachelin with respect to the sequestering 
of trace metals, is discussed above. Other 
examples include bioactive metabolites 
such as the cyanobacterial toxins.
Up to now over one hundred different 
bioactive compounds have been character-
ized from cyanobacteria. These neuro- and 
hepatotoxins include well-known com-
pounds such as microcystin, saxitoxin and 
anatoxin [18]. The ecological role of these 
agents is suggested to be related to deter-
rent purposes with respect to grazing by 
insects. Another class of cyanobacterial 
metabolites is directed towards competing 
photosynthetic species. For example, pho-
tosystem II inhibitors such as fischerellin 
A are thought to secure an evolutionary ad-
vantage by poisoning algae competing for 
the same resources [19].
While many bioactive compounds of 
cyanobacterial origin belong to the chemi-
cal class of modified peptides or mixed 
polyketide/peptide species [20], some al-
kaloids have also been isolated and charac-
terized from cyanobacteria. In addition to 
the above-mentioned fischerellin, alkaloids 
with appealing molecular structure such as 
welwitindoline A (2) isolated from Hapalo­
siphon weilwitschi [21], and more simple 
fragments such as the bauerines (3a-c) [22] 
or norharmane (4) [23] and harmane [24] 
were isolated (Fig. 2).
In collaboration with the group of Prof. 
Dr. Friedrich Jüttner from the University 
of Zürich, we have characterized nostocar-
boline (5) from the toxic blue-green algae 
Nostoc 78-12A [25] (Fig. 3). This cyano-
bacterium, originally isolated from a waste-
water lagoon in the USA, was reported to 
produce secondary metabolites with activi-
ties against photosynthetic organisms [26]. 
Bioassay-guided fractionation resulted in 
the identification of nostocarboline (5), or 
6-chloro-2-methyl-carbolinium [27]. Com-
pound 5 is a so-called anhydronium base, 
a term coined by Sir Robert Robinson for 
bases [28], in which the proton and the pos-
itive charge (and thus the counterion) are 
spatially separated.
Nostocarboline (5) was found to be a 
potent inhibitor of butyrylcholinesterase, 
with an IC50 of 13.2 µM. This value is 
slightly lower that of galanthamine (6, 16.9 
µM), which is on the market as a drug to 
treat Alzheimer’s disease [29]. The related 
deschloro compound 7 has also a similar 
IC50 value. Interestingly, this compound 
is endogenous to humans, and its physi-
ological role is unclear [29] (Fig. 3). Some 
reports raise the possibility that this com-
pound is related to 1-methyl-4-phenylpyri-
dinium (TPP), a known neurotoxin. Our 
data establishes that 2-methyl norhamane 7 
is a butyrylcholinesterase inhibitor and this 
could imply such a physiological role for 
this orphan ligand [25]. As a side note, there 
are only few human alkaloids known such 
as harmane and norharmane. The physi-
ological role of these remains the subject 
of intense scientific debate.
The producing strain Nostoc 78-12A 
was noted as anticyanobiotic by Flores and 
Wolk in the context of isolating and cultur-
ing this cyanobacterium [26]. Based on this 
precedent, we screened for phytotoxic prop-
erties of nostocarboline (5) to investigate 
whether this compound was responsible for 
the reported biological activity of the par-
ent Nostoc strain. In fact, nostocarboline (5) 
was found to be very active against both pro-
karyotic and eukaryotic photoautotrophs, 
Fig. 1. Anachelin (1), a structural natural product hybrid featuring alkaloid, 
peptide and polyketide biosynthetic pathways
Fig. 2. Alkaloids 2–4 isolated from cyanobacteria
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with minimal inhibitory concentrations as 
low as 100 nM [30]. This exceptionally low 
value in cell-based assays is remarkable, as 
the charged compound must first enter the 
cell and reach the target. Nostocarboline (5) 
was not active against non-photosynthetic 
pathogenic bacteria and fungi, which points 
to a target related to photosynthetic process-
es [31]. This is interesting, as the producing 
organism relies on photosynthesis as well. 
Autotoxicity of 5 against its producer was 
not found to be an issue (2 to 3 orders of 
magnitude of difference in MIC values), 
and exactly this difference could allow for 
evolutionary advantage against competing 
photoautotrophs [30].
Next, we asked whether the activity of 
5 could be broadened to also include regu-
lar, non-photosynthetic bacteria. Such com-
pound would prevent the growth of any pro-
karyotic and photoautotrophic organisms 
and could find interesting applications in 
biofilm control. The adhesion of bacteria, 
algae and higher organisms on the surfaces 
of ships, pipelines and platforms, as well as 
pipe systems for example in nuclear power 
plants constitutes a significant challenge. 
The problems are accentuated, as resis-
tance towards Cu-based antifouling paints 
is quickly developing, and traditional tin-
based agents are increasingly being banned 
worldwide.
In order to broaden the activity of the 
phycotoxic agent nostocarboline, we pre-
pared the hybrid 8 between nostocarboline 
(5) and ciprofloxacin (9), a very potent gy-
rase inhibitor and antibacterial agent. Both 
compounds are linked via an aryl linker to 
furnish the nostocarboline/ciprofloxacin 
hybrid 8 [30]. This compound has a unique 
profile of action retaining the phytotoxic 
properties of nostocarboline as well as the 
antibacterial activity of ciprofloxacin. MIC 
values as low as 0.7 µM against E. coli as 
well as 1 µM against the cyanobacterium 
M. aeruginosa have been determined. Simi-
lar quinolone chimeras have been reported 
to broaden antibacterial activity with con-
comitant decrease of resistance [32].
Chemically, hybridizing a putative pho-
tosynthesis inhibitor 5 and a gyrase inhibitor 
9 (Fig. 4) without deterioration of potency is 
challenging as both targets must be reached 
by the same small molecule inhibitor. As 
this example shows, successful hybridiza-
tion is only possible if structure–activity 
(SAR) relationships have been established. 
In this case, our work on nostocarboline 
(5) demonstrated that replacement of the 
2-Me group by benzyl retained or slightly 
increased the activity [30]. Detailed SAR 
for ciprofloxacin (9) is well documented 
in the literature. This hybrid between the 
natural product nostocarboline and the syn-
thetic (natural product derived) ciprofloxa-
cin clearly demonstrates the power of the 
hybridization approach in combining and 
broadening bioactivity.
4. Higher Order Hybrids
As discussed above, the low bioavail-
ability of iron has another consequence for 
the molecular mechanism of cyanobacte-
rial iron acquisition. The prevalence of the 
dominant iron oxide hydrates requires that 
siderophores recognize and bind to the sol-
id oxide surfaces. Siderophores were thus 
probably not only evolved to bind iron ions, 
but also to recognize and bind iron oxide 
surfaces. This hypothesis is supported by 
several studies demonstrating siderophore 
mineral interactions [33]. In particular there 
was one report of bacterial adhesion medi-
ated by siderophores on titanium oxide 
surfaces [34]. Consequently, we postulated 
that siderophores are able to bind to metal 
oxides surfaces in general.
In order to test this hypothesis, the 
catecholate fragment of the siderophore 
anachelin (1) was hybridized to poly-
ethylene glycol (PEG) and the resulting 
conjugate 10 (Fig. 5) evaluated for surface 
binding [35]. This potential success of this 
design is supported by several distinct 
structural features. First, the anachelin 
chromophore (the catecholate) could be 
biosynthetically related to dihydroxyphe-
nylalaine (DOPA). This amino acid was 
found to be present in high content in so-
called mussel adhesive proteins, which al-
low the mussels to bind to many surfaces 
Fig. 3. Nostocarboline (5), isolated from Nostoc 78-12A, is a potent inhibitor of butyrylcholinesterase 
of similar activity compared to galanthamine (6) and deschloronostocarboline (7). the latter compound 
was found in post-mortem human brain (‘human alkaloid’) [29].
Fig. 4. the nostocarboline ciprofloxacin hybrid 8 and the parent antibacterial agent, ciprofloxacin (9).
Fig. 5. the natural product lead, anachelin (1), allowed for the design of the natural product hybrid 10 
consisting of the anachelin chromophore and poly-ethyleneglycol
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under difficult conditions [36]. Oligomers 
of DOPA were also successfully used to 
modify titanium oxide surfaces [37]. Sec-
ond, the positive charge of the anachelin 
chromophore might contribute favorably 
to the binding enthalpy with the nega-
tively charged surfaces (cf. also the poly-
cationic surface active polymers [38]). 
Third, the PEG chains could in principle 
allow for the prevention of the unwanted 
attachment of proteins to the surface [39]. 
A requirement for this would be that they 
could be densely packed on the surface to 
form stable polymer brushes.
The synthesis of the anachelin chro-
mophore PEG conjugate was based on the 
biomimetic assembly of the tetrahydro-
quinolinium system. To achieve this goal, 
DOPA was converted to the precursor 11 
[14][16][17]. The diamine 11 served as 
substrate for the biomimetic oxidative aza 
annulation reaction. Treatment of 11 with a 
tellurium oxide resulted in the clean forma-
tion of the tetrahydroquinolinium system 
12 (Scheme 1).
As such, tellurium oxides should not 
be considered as biomimetic, as this cy-
clization probably involves enzymatic 
catalysis. Such a candidate could origi-
nate from the family of catechol oxidas-
es. These enzymes oxidize catechols to 
quinones and are involved in many bio-
chemical processes such as melanin (skin 
pigment) formation. We were pleased to 
find that treatment of the diamine 11 with 
tyrosinase resulted in the clean formation 
of the anachelin chromophore 12 [14]. As 
tyrosinase can be extracted directly from 
mushrooms and this procedure is applica-
ble on a preparative scale, this route opens 
a favorable biotechnological preparation 
of this key compound (Scheme 2). Depro-
tection of the Boc group and conjugation 
to commercially available PEG-5000 ac-
tive ester gave the hybrid 10, which was 
purified by size exclusion chromatogra-
phy [35].
The anachelin chromophore PEG chi-
mera is then dissolved under dilute condi-
tions (1 mg/ml) and the hybridization with 
the TiO2 surface is carried out under cloud 
point conditions by a simple dip and rinse 
procedure in 4 h [35]. The resulting adlay-
ers of 10 were characterized by various 
techniques such as variable angle spec-
troscopic ellipsometry, X-ray photoelec-
tron spectroscopy and optical waveguide 
lightmode spectroscopy [35]. All these 
data support the presence of monomolec-
ular self-assembled layers on the titanium 
oxide surface. It is reasonable to assume 
that there is covalent attachment of these 
compounds on TiO2, based on literature 
precedence of related systems [37].
These resulting adlayers were also 
characterized from the protein resistance 
properties, i.e. whether the modified sur-
faces will be resistant to the attachment of 
proteins from serum. This so-called bio-
fouling is a serious problem in medicine, 
and a large part of research in biomedical 
engineering is devoted to the generation 
of such protein resistant surfaces. Interest-
ingly, the surfaces coated with the anach-
elin chromophore PEG conjugate were 
highly resistant towards the attachment 
of proteins from serum. This correlates in 
general well with a dense packing of the 
polymer brushes on the surface (Fig. 6). 
Control experiments involving different 
linkers such as dopamine, minosine and 
DOPA all resulted in lower adlayer thick-
ness and therefore a dramatic loss of pro-
tein resistance [35].
The hybrid 13 can be considered to 
possess ternary structure, as three differ-
ent chemical structures (TiO2, anachelin 
chromophore, and PEG) with different 
functional properties (solid support, bind-
ing and protein resistance) are combined. 
This exemplifies the power of natural 
product hybrids as fundamentally differ-
ent properties can be combined to gener-
ate innovative solutions for challenges in 
medicine.
scheme 1. preparation of the anachelin chromophore
scheme 2. Enzymatic preparation of the anachelin chromophore 12 and its conversion to the pEG 
conjugate 10
Fig. 6. the ternary conjugate 16, hybridizing three different chemical structures with different functions. 
the resulting assembled monolayer is thought to form tightly packed brushes.
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5. Conclusion
This highlight article gives an overview 
over different classes of natural product 
hybrids. Structural natural product hybrids 
can be considered as compounds in which 
fragments of different biosynthetic origin 
are combined. This is exemplified by the 
cyanobacterial siderophore anachelin, 
which is composed of alkaloid, unnatural 
peptide and polyketide fragments. A sec-
ond class is composed of functional natural 
product hybrids, where substructures with 
different biological functions are com-
bined. As an example, the hybrid between 
nostocarboline and ciprofloxacin was dis-
cussed, which delivers an unprecedented 
broad spectrum of biological activity. Last, 
higher order hybrids were introduced by the 
ternary compound TiO2-anachelin chromo-
phore and PEG. This example is interesting 
since inorganic metal oxides are hybridized 
to a natural product and a synthetic polymer 
to generate protein-resistant surfaces. This 
ternary hybrid also shows the possibilities 
in designing and tailoring more complex 
hybrids that can be used to suit a well-de-
fined molecular function.
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